1. Home
  2. FRMM vs MCRB Comparison

FRMM vs MCRB Comparison

Compare FRMM & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMM

Forum Markets Incorporated Common Stock

N/A

Current Price

$5.29

Market Cap

75.7M

Sector

Health Care

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$4.65

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMM
MCRB
Founded
N/A
2010
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.7M
71.0M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
FRMM
MCRB
Price
$5.29
$4.65
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$14.00
AVG Volume (30 Days)
353.5K
97.6K
Earning Date
05-26-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
$183.55
N/A
Revenue Next Year
$166.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$4.59
52 Week High
$7.15
$29.98

Technical Indicators

Market Signals
Indicator
FRMM
MCRB
Relative Strength Index (RSI) 44.94 29.94
Support Level $4.78 N/A
Resistance Level $5.60 $9.53
Average True Range (ATR) 0.57 0.45
MACD -0.13 -0.08
Stochastic Oscillator 11.11 7.31

Price Performance

Historical Comparison
FRMM
MCRB

About FRMM Forum Markets Incorporated Common Stock

Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: